QA: Catalent Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001596783_2023_Catalent_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Liabilities" added to remainder. industry.us_generic {'missing_ratio': 3.5427892234548337, 'aggregate_val': 5733000000, 'exp_sum': 1262000000, 'exp_to_value': {'LiabilitiesCurrent': 1098000000, 'LiabilitiesNoncurrent': 164000000, 'remainder_Liabilities': 0}}

Graph

Absolute values for 0001596783, Catalent Inc

  xvar xval
0 AssetsCurrent 2,917,000,000
1 IntangibleAssetsNetIncludingGoodwill 4,066,000,000
2 PropertyPlantAndEquipmentNet 3,127,000,000
3 remainder_Assets 398,000,000
4 LiabilitiesCurrent 1,098,000,000
5 LiabilitiesNoncurrent 164,000,000
6 remainder_Liabilities 4,471,000,000
7 CostOfGoodsAndServicesSold 3,479,168,548
8 SellingGeneralAndAdministrativeExpense 890,448,851
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 122,656,563
11 remainder_Revenues 5,168,346,632
12 remainder_NetIncome -66,441,796
13 remainder_ComprehensiveNetIncome -22,415,530
  yvar yval
0 Assets 10,508,000,000
1 Liabilities 5,733,000,000
2 Expenses 4,492,273,962
3 Revenues 5,168,346,632
4 StockholdersEquity 4,775,000,000
5 NetIncome 609,630,874
6 ComprehensiveNetIncome 598,423,109
7 BaseVar 12,995,238,960
8 EconomicCapitalRatiobeforeLimitedLiability 1.36
9 EconomicCapitalRatio 2.57

Edgar->Model Mapping

Feature Distribution

Change over Time